Conference Calendar - The 88th EAS Congress

All times are in CET (Central European Time)

Displaying One Session

View

Joint symposium

ESC-EAS joint symposium - A Deep Dive into ESC/EAS Dyslipidemia Guidelines

Session Type

Joint symposium

Chair(s)

Lale Tokgözoğlu, Turkey

Room

Hall 1

Date

05.10.2020, Monday

Session Time

10:00 - 11:10

Session Ticket

Session Evaluation

Option 1

Watch Stream
Session Webcast

Session Webcast

[{"name":"Introduction","mode":"playlist","public":true,"info":{"id":1542,"presentation":"Introduction","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Lale Tokg\u00f6zo\u011flu, Turkey","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5284.jpg"},"playlist":[{"name":"Introduction","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/Lale Intro.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/Lale Intro.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/68B3C613.jpg","data":[],"tracks":[]}]},{"name":"How to approach a patient with dyslipidemia without apparent CAD","mode":"playlist","public":true,"info":{"id":1772,"presentation":"How to approach a patient with dyslipidemia without apparent CAD","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Baris Gencer, Switzerland","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/Baris Gencer - EAS20 - 1772 - How to approach a patient with dyslipidaemia without apparent CAD.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/Baris Gencer - EAS20 - 1772 - How to approach a patient with dyslipidaemia without apparent CAD.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/5C593835.jpg","data":[],"tracks":[]}]},{"name":"How to approach a patient with dyslipidemia without apparent CAD. What the guideline says.","mode":"playlist","public":true,"info":{"id":1423,"presentation":"How to approach a patient with dyslipidemia without apparent CAD. What the guideline says.","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Victoria Delgado, Netherlands","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/5317.jpg"},"playlist":[{"name":"How to approach a patient with dyslipidemia without apparent CAD (case by young fellow) What the gui","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1423.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/1423.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/F95B53DA.jpg","data":[],"tracks":[]}]},{"name":"What is the critical evidence behind the guideline:","mode":"playlist","public":true,"info":{"id":1424,"presentation":"What is the critical evidence behind the guideline:","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"What is the critical evidence","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/20.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/20.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/685A78AF.jpg","data":[],"tracks":[]}]},{"name":"How to approach a patient with dyslipidemia with CAD","mode":"playlist","public":true,"info":{"id":1773,"presentation":"How to approach a patient with dyslipidemia with CAD","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Anna Lebedeva, Russian Federation","photo":""},"playlist":[{"name":"How to approach a patient with dyslipidemia with CAD","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1773 attempt 1.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/1773 attempt 1.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/F7187F4.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1773 attempt 1.vtt"}]},{"name":"How to approach a patient with dyslipidemia with CAD (case by young fellow) What the guideline says","mode":"playlist","public":true,"info":{"id":1425,"presentation":"How to approach a patient with dyslipidemia with CAD (case by young fellow) What the guideline says","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Fran\u00e7ois Mach, Switzerland","photo":"https:\/\/cslide.ctimeetingtech.com\/global_storage\/media\/content\/eas20\/persons\/photos\/99.jpg"},"playlist":[{"name":"Mach- EAS20 - 1425 -How to approach a patient with dyslipidemia with CAD (case by young fellow) Wha","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/1425.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/1425.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/761BA67A.jpg","data":[],"tracks":[]}]},{"name":"What is the critical evidence behind the guideline:","mode":"playlist","public":true,"info":{"id":1426,"presentation":"What is the critical evidence behind the guideline:","session":"ESC-EAS joint symposium - A Deep Dive into ESC\/EAS Dyslipidemia Guidelines","presenter":"Alberico Luigi Catapano, Italy","photo":""},"playlist":[{"name":"1426-What is the critical evidence behind the guideline:","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/EAS201426.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/8\/EAS201426.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/8\/E1EAE43A.jpg","data":[],"tracks":[]}]}]